Orion Genomics Licenses Methylation Screening Tech to Qiagen to Use in qPCR-Based Epigenetics Kits
September 22, 2011
Orion Genomics Licenses Methylation Screening Tech to Qiagen to Use in qPCR-Based Epigenetics Kits
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Orion Genomics Licenses Methylation Technology to Qiagen
September 21, 2011 / GenomeWeb Daily News - Oligo-Based Protein Capture Tools Allow Simultaneous Reporting of Genetic, Proteomic Biomarker Data
October 21, 2011 / ProteoMonitor - Cepheid, OHSU Co-developing Cancer MDx Tests for GeneXpert
February 19, 2013 / GenomeWeb Daily News - Cepheid Provides Update on MDx Pipeline with Focus on CT/NG, TB, Oncology
September 20, 2012 / PCR Insider - Cepheid Provides Update on Dx Menu Expansion; Oncology Plans Include Breast Cancer Recurrence Test
September 22, 2011 / PCR Insider